• Home
  • NEW DAY MEDICINE
  • 9 (59) 2023
  • 3 -9 (59) 2023 — Mammadova H.H. — EXACERBATION OF INFLAMMATORY INDICATORS IN INFECTION COVID-19 ROLE IN DEGREE ASSESSMENT

3 -9 (59) 2023 — Mammadova H.H. — EXACERBATION OF INFLAMMATORY INDICATORS IN INFECTION COVID-19 ROLE IN DEGREE ASSESSMENT

EXACERBATION OF INFLAMMATORY INDICATORS IN INFECTION COVID-19 ROLE IN DEGREE ASSESSMENT

Mammadova H.H. Azerbaijan Medical University, Department of Infectious Diseases, Baku Samad Vurgun

Resume

COVID-19 is an infectious disease caused by SARS-CoV-2 infection. Many methods are used to assess the spread, course, and severity of infection in a timely and accurate manner. Firstly, the diagnostic method using RT-PCR using only swabs from the nasopharynx or oropharynx sometimes gives false results, so other examination methods are used. Recent studies have shown that an important role in assessing the prognosis of the disease is played by biochemical parameters of peripheral blood tests, including inflammatory parameters (CRP, ECS, PCT, etc.).

In this study, we statistically analyzed the parameters of C-reactive protein, ferritin and PCT in a group of patients with complications and found out how important they are in assessing the course of the disease.

The study compared inflammation parameters in blood samples taken at regular intervals from 212 patients diagnosed with Covid-19, divided into age and gender categories. As a result, the importance of such indicators as procalcitonin, C-reactive protein and ferritin in assessing the degree of complications was emphasized.

Keywords: Covid-19, ferritin, CRP, PCT, ESR

First page

12

Last page

17

For citation: Mammadova H.H. – EXACERBATION OF INFLAMMATORY INDICATORS IN INFECTION COVID-19 ROLE IN DEGREE ASSESSMENT //New Day in Medicine 2023 9(59): 12-17 https://newdaymedicine.com/index.php/2023/09/05/l-341/

LIST OF REFERENCES:

  1. C. Zhou, Y. Chen, Y. Ji, et al., Increased serum levels of hepcidin and ferritin are associated with severity of COVID-19, Med. Sci. Mon. Int. Med. J. Exp.
  2. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus. //J Exp Med 1930;52:561–571.
  3. Morley JJ , Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982;389:406–418.
  4. Murashima M, Nishimoto M, Kokubu M, Hamano T, Matsui M, Eriguchi M, Samejima KI, Akai Y, Tsuruya K. Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep 2019;9:20260.
  5. Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. //J Clin Lab Anal. 2020 Oct;34(10):e23618. doi: 10.1002/jcla.23618.                                                                                                                                     
  6. Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175. doi:10.1177/1753466620937175..
  7. Bozkurt FT, Tercan M, Patmano G, Bingol Tanrıverdi T, Demir HA, Yurekli UF. Can Ferritin Levels Predict the Severity of Illness in Patients With COVID-19 Cureus. 2021 Jan;13(1):1–8.
  8. Ariza R, Messah AD, Sinaga F, Wahyudi A, Pratama SA, Annisa I. Korelasi Gambaran Radiografi Toraks dengan Karakteristik Klinis Pasien Terkonfirmasi Covid-19. Arter J Ilmu Kesehat. 2021;2(1):15–22.
  9. Rajanna AH, Krishnegowda R, Govindaiah RM. To Correlate Serum Ferritin Levels with Clinical Outcome in Covid-19 Patients. Asian J Med Sci. 2021;12(5):25–29.
  10. Kemenkes RI. COVID-19 INDONESIA Per 16 Mei 2021. INFEKSI EMERGING Media Inf Resmi Terkini Penyakit Infeksi Satuan Satgas Penanganan COVID-19. Analisa Data COVID-19 Indonesia
  11. Kangdra WY. Karakteristik Klinis Dan Faktor Komorbid Pada Pasien Dalam Pengawasan (PDP) Coronavirus Disease 2019 (COVID-19) di RS Mitra Medika
  12. Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, Song Q, Jia Q, Wang J. . Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15(7):1–13.
  13. Wang W, Knovich MA, Coffman LG, Torti FM, Torti S V. Serum ferritin: Past, present, and future. Biochim Biophys Acta. 2020;1800(8):760–76                                                                                                                                  
  14. C. Ros´ario, G. Zandman-Goddard, E.G. Meyron-Holtz, et al., The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome, BMC Med. 1 (2013)185.
  15. S. Colafrancesco, C. Alessandri, F. Conti, et al., COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome Autoimmun. Rev. 1
  16. G. Lippi, M. Plebani, B.M. Henry, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a metaanalysis, Clin. Chim. Acta 506 (2020) 145-148.                                                                                                                  
  17. F. Zhou, T. Yu, R. Du, et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet 395 (10229) (2020) 1054–1062.
  18. G. Dimopoulos, Q. de Mast, N. Markou, et al., Favorable Anakinra responses in severe COVID-19 patients with secondary hemophagocytic lymphohistiocytosis,Cell Host Microbe 28 (2020) 117–123.
  19. X. Xu, M. Han, T. Li, et al., Effective treatment of severe COVID-19 patients with tocilizumab, Proc. Natl. Acad. Sci. USA 2020;117(20):10970–10975.

file

download